35th European Congress of Pathology

Unleashing the Power of Molecular Testing: Liquid Biopsy and Comprehensive Genomic Profiling in Precision Oncology – On Demand

Did you miss the opportunity to join us at ECP 2023 and enhance your familiarity with most recent molecular next generation sequencing (NGS) approaches, crucial for fast and effective biomarker identification in solid tumours? 

Access our on-demand content and discover:

• The impact and importance of upfront fast NGS genomic testing in NSCLC and how the complementarity between FFPE and liquid biopsy testing
• How comprehensive genomic profiling (CGP) is enhancing precision medicine and advancing our understanding of cancer biology

Next generation sequencing testing at
Cork University Hospital

Reiltin Werner
Cork University Hospital, Ireland

> Access Presentation

Feasibility study comparing tissue and blood profiles at baseline for the identification of genomic alterations

Dr. Simonetta Buglioni
Istituti Fisioterapici Ospedalieri (IFO), Italy

> Access Presentation

Exploring the impact of comprehensive genomic profiling in solid tumour testing

Dr. Gorka Alkorta
CIMA LAB Diagnostics, Universidad de Navarra, Spain

> Access Presentation

Ovarian cancer testing: unveil homologous ecombination deficiency (HRD) through CGP NGS analysis

Dr. Annette Staebler
Universitätsklinikum Tübingen, Germany

> Access Presentation

Thermo Fisher Scientific Posters

Continuing Innovation in Clinical Research

 

 

Request to speak with a Thermo Fisher Scientific representative below.

For Research Use Only. Not for diagnostics procedures.